Research programme: epithelial sodium channel modulators - Spyryx Biosciences
Latest Information Update: 01 Jun 2015
At a glance
- Originator Spyryx Biosciences
- Class Peptides
- Mechanism of Action Epithelial sodium channel-antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Chronic obstructive pulmonary disease
Most Recent Events
- 13 Feb 2015 Early research in Chronic obstructive pulmonary disease in USA (Inhalation)